Profitelligence Profitelligence · Filing Ledger Search all insiders →

Insider Profile · SEC Form 4 Activity · Trailing 90 Days

Clark Ian T

Over the trailing 90 days, Clark Ian T (Director at Guardant Health, Inc.) sold $735K of stock across 5 companies, per 9 SEC Form 4 transactions.

Role
Director
Companies
GH KYTX OLMA CRVS BMRN
Window
Trailing 90 days · 9 transactions · CIK 1336504
Net activity
−$735K ($0 bought · $735K sold)

By Company (Trailing 90 Days)

SymbolCompanyTxnsBoughtSoldNet
GHGuardant Health, Inc.4$735K−$735K
OLMAOlema Pharmaceuticals, Inc.1$0
CRVSCorvus Pharmaceuticals, Inc.1$0
BMRNBIOMARIN PHARMACEUTICAL INC1$0
KYTXKyverna Therapeutics, Inc.2$0

Transactions (9)

DateSymbolTypeSharesValueDescription
2026-06-18OLMABuy29.5K$0Grant, award or other acquisition
2026-06-17GHBuy2.7K$0Grant, award or other acquisition
2026-06-17GHSell5.1K$0Exercise or conversion of derivative security
2026-06-17GHBuy5.1K$0Exercise or conversion of derivative security
2026-06-11CRVSBuy15.0K$0Grant, award or other acquisition
2026-06-02BMRNBuy7.5K$0Grant, award or other acquisition
2026-05-27KYTXBuy20.6K$0Grant, award or other acquisition
2026-05-27KYTXBuy5.1K$0Grant, award or other acquisition
2026-05-20GHSell6.9K$735KOpen market or private sale

Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.

Follow Clark's next move

Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.

Start free